Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases of the Nervous System

Explore clinical trials studying Autoimmune Diseases of the Nervous System. Study availability and eligibility vary by location and protocol.

3,227 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases of the Nervous System trial results

Completed

Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)

NCT02159573

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Cullman, Alabama, United States
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
View all 43 locations
View Trial Details
Completed

A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720

NCT01578330

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)
  • Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)
  • Novartis Investigative Site Bursa, Turkey, Turkey (Türkiye)
  • Novartis Investigative Site Izmir, Turkey, Turkey (Türkiye)
View Trial Details
Completed

Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse

NCT01986998

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Hospital Universitari Germans Trias I Pujol de Badalona, Barcelona, Spain
  • Hospital Del Mar Barcelona, Spain
  • Hospital de Mataró Barcelona, Spain
  • Hospital Clinic I Provincial de Barcelona Barcelona, Spain
View Trial Details
Completed

Efficacy of Methotrexate in Myasthenia Gravis

NCT00814138

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Phoenix Neurological Associates Phoenix, Arizona, United States
  • University of California, San Francisco Fresno, California, United States
  • University of California-Irvine Irvine, California, United States
  • Forbes Norris MDA/ALS Research Center San Francisco, California, United States
View all 16 locations
View Trial Details
Completed

Natalizumab Temporary Discontinuation Study

NCT02775110

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Buffalo Neuroimaging Analysis Center Buffalo, New York, United States
  • Jacobs Neurological Institute Buffalo, New York, United States
View Trial Details

Related conditions